vs

Side-by-side financial comparison of FORWARD AIR CORP (FWRD) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $631.2M, roughly 1.5× FORWARD AIR CORP). FORWARD AIR CORP runs the higher net margin — -4.5% vs -15.2%, a 10.7% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -0.3%). Over the past eight quarters, FORWARD AIR CORP's revenue compounded faster (7.9% CAGR vs 0.4%).

Forward Air Corp is a leading North American asset-light logistics and transportation provider. It offers core services including expedited less-than-truckload freight delivery, final-mile logistics, intermodal transport, warehousing, and supply chain solutions, serving key sectors such as e-commerce, retail, manufacturing, and automotive across the U.S., Canada, and Mexico.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

FWRD vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.5× larger
XRAY
$961.0M
$631.2M
FWRD
Growing faster (revenue YoY)
XRAY
XRAY
+6.4% gap
XRAY
6.2%
-0.3%
FWRD
Higher net margin
FWRD
FWRD
10.7% more per $
FWRD
-4.5%
-15.2%
XRAY
Faster 2-yr revenue CAGR
FWRD
FWRD
Annualised
FWRD
7.9%
0.4%
XRAY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FWRD
FWRD
XRAY
XRAY
Revenue
$631.2M
$961.0M
Net Profit
$-28.3M
$-146.0M
Gross Margin
46.1%
Operating Margin
-0.5%
-14.5%
Net Margin
-4.5%
-15.2%
Revenue YoY
-0.3%
6.2%
Net Profit YoY
22.2%
66.0%
EPS (diluted)
$-0.90
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FWRD
FWRD
XRAY
XRAY
Q4 25
$631.2M
$961.0M
Q3 25
$631.8M
$904.0M
Q2 25
$618.8M
$936.0M
Q1 25
$613.3M
$879.0M
Q4 24
$632.8M
$905.0M
Q3 24
$655.9M
$951.0M
Q2 24
$643.7M
$984.0M
Q1 24
$541.8M
$953.0M
Net Profit
FWRD
FWRD
XRAY
XRAY
Q4 25
$-28.3M
$-146.0M
Q3 25
$-16.3M
$-427.0M
Q2 25
$-12.6M
$-45.0M
Q1 25
$-50.6M
$20.0M
Q4 24
$-36.4M
$-430.0M
Q3 24
$-73.4M
$-494.0M
Q2 24
$-645.4M
$-4.0M
Q1 24
$-61.7M
$18.0M
Gross Margin
FWRD
FWRD
XRAY
XRAY
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Q1 24
53.1%
Operating Margin
FWRD
FWRD
XRAY
XRAY
Q4 25
-0.5%
-14.5%
Q3 25
2.4%
-24.1%
Q2 25
3.2%
-13.7%
Q1 25
0.8%
7.2%
Q4 24
12.0%
-56.2%
Q3 24
3.5%
-48.6%
Q2 24
-170.2%
5.1%
Q1 24
-12.1%
4.4%
Net Margin
FWRD
FWRD
XRAY
XRAY
Q4 25
-4.5%
-15.2%
Q3 25
-2.6%
-47.2%
Q2 25
-2.0%
-4.8%
Q1 25
-8.3%
2.3%
Q4 24
-5.8%
-47.5%
Q3 24
-11.2%
-51.9%
Q2 24
-100.3%
-0.4%
Q1 24
-11.4%
1.9%
EPS (diluted)
FWRD
FWRD
XRAY
XRAY
Q4 25
$-0.90
$-0.74
Q3 25
$-0.52
$-2.14
Q2 25
$-0.41
$-0.22
Q1 25
$-1.68
$0.10
Q4 24
$-1.69
$-2.09
Q3 24
$-2.66
$-2.46
Q2 24
$-23.47
$-0.02
Q1 24
$-2.81
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FWRD
FWRD
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$106.0M
$326.0M
Total DebtLower is stronger
$1.7B
$2.3B
Stockholders' EquityBook value
$113.3M
$1.3B
Total Assets
$2.7B
$5.4B
Debt / EquityLower = less leverage
14.89×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FWRD
FWRD
XRAY
XRAY
Q4 25
$106.0M
$326.0M
Q3 25
$140.4M
$363.0M
Q2 25
$95.1M
$359.0M
Q1 25
$116.3M
$398.0M
Q4 24
$104.9M
$272.0M
Q3 24
$136.6M
$296.0M
Q2 24
$84.9M
$279.0M
Q1 24
$152.0M
$291.0M
Total Debt
FWRD
FWRD
XRAY
XRAY
Q4 25
$1.7B
$2.3B
Q3 25
$1.7B
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
$1.7B
Stockholders' Equity
FWRD
FWRD
XRAY
XRAY
Q4 25
$113.3M
$1.3B
Q3 25
$139.8M
$1.5B
Q2 25
$151.8M
$2.0B
Q1 25
$154.6M
$2.0B
Q4 24
$201.7M
$1.9B
Q3 24
$226.1M
$2.5B
Q2 24
$283.8M
$3.1B
Q1 24
$926.1M
$3.3B
Total Assets
FWRD
FWRD
XRAY
XRAY
Q4 25
$2.7B
$5.4B
Q3 25
$2.8B
$5.7B
Q2 25
$2.8B
$6.1B
Q1 25
$2.8B
$6.0B
Q4 24
$2.8B
$5.8B
Q3 24
$3.1B
$6.6B
Q2 24
$3.1B
$6.9B
Q1 24
$4.0B
$7.1B
Debt / Equity
FWRD
FWRD
XRAY
XRAY
Q4 25
14.89×
1.70×
Q3 25
12.05×
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24
1.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FWRD
FWRD
XRAY
XRAY
Operating Cash FlowLast quarter
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
1.3%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FWRD
FWRD
XRAY
XRAY
Q4 25
$101.0M
Q3 25
$52.7M
$79.0M
Q2 25
$48.0M
Q1 25
$27.6M
$7.0M
Q4 24
$-23.2M
$87.0M
Q3 24
$51.2M
$141.0M
Q2 24
$-45.2M
$208.0M
Q1 24
$-51.7M
$25.0M
Free Cash Flow
FWRD
FWRD
XRAY
XRAY
Q4 25
$60.0M
Q3 25
$48.6M
$40.0M
Q2 25
$16.0M
Q1 25
$15.7M
$-12.0M
Q4 24
$-30.5M
$36.0M
Q3 24
$40.7M
$98.0M
Q2 24
$-59.6M
$156.0M
Q1 24
$-56.7M
$-9.0M
FCF Margin
FWRD
FWRD
XRAY
XRAY
Q4 25
6.2%
Q3 25
7.7%
4.4%
Q2 25
1.7%
Q1 25
2.6%
-1.4%
Q4 24
-4.8%
4.0%
Q3 24
6.2%
10.3%
Q2 24
-9.3%
15.9%
Q1 24
-10.5%
-0.9%
Capex Intensity
FWRD
FWRD
XRAY
XRAY
Q4 25
1.3%
4.3%
Q3 25
0.7%
4.3%
Q2 25
0.8%
3.4%
Q1 25
1.9%
2.2%
Q4 24
1.1%
5.6%
Q3 24
1.6%
4.5%
Q2 24
2.2%
5.3%
Q1 24
0.9%
3.6%
Cash Conversion
FWRD
FWRD
XRAY
XRAY
Q4 25
Q3 25
Q2 25
Q1 25
0.35×
Q4 24
Q3 24
Q2 24
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FWRD
FWRD

Omni Logistics Segment$359.8M57%
Network$183.9M29%
Intermodal Segment$50.2M8%
Truckload$41.6M7%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons